Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review

Medullary thyroid cancer (MTC) is a rare but aggressive thyroid malignancy. The gold-standard biomarker for its diagnosis and follow-up is calcitonin (CT); however, it has a variable half-life dependent on its circadian variability. It has been suggested that a more stable hormone, procalcitonin (PC...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anticancer research 2016-08, Vol.36 (8), p.3803-3810
Hauptverfasser:	Karagiannis, Apostolos K A, Girio-Fragkoulakis, Constantine, Nakouti, Theodora
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - genetics Calcitonin - genetics Calcitonin - therapeutic use Carcinoma, Neuroendocrine - diagnosis Carcinoma, Neuroendocrine - genetics Carcinoma, Neuroendocrine - pathology Carcinoma, Neuroendocrine - therapy Circadian Clocks - genetics Humans Thyroid Neoplasms - diagnosis Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology Thyroid Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!